Erste Asset Management GmbH Sells 3,812 Shares of HCA Healthcare, Inc. $HCA

Erste Asset Management GmbH cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 60.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,502 shares of the company’s stock after selling 3,812 shares during the period. Erste Asset Management GmbH’s holdings in HCA Healthcare were worth $1,053,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Generali Investments Management Co LLC boosted its stake in shares of HCA Healthcare by 65.5% during the third quarter. Generali Investments Management Co LLC now owns 2,328 shares of the company’s stock valued at $992,000 after purchasing an additional 921 shares in the last quarter. DNB Asset Management AS grew its holdings in HCA Healthcare by 0.7% during the 3rd quarter. DNB Asset Management AS now owns 33,960 shares of the company’s stock worth $14,474,000 after acquiring an additional 246 shares during the last quarter. Hohimer Wealth Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at $632,000. West Family Investments Inc. grew its stake in shares of HCA Healthcare by 31.5% in the third quarter. West Family Investments Inc. now owns 806 shares of the company’s stock worth $344,000 after purchasing an additional 193 shares during the last quarter. Finally, Advisor OS LLC raised its position in HCA Healthcare by 9.0% during the 3rd quarter. Advisor OS LLC now owns 1,356 shares of the company’s stock worth $578,000 after purchasing an additional 112 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 15,214 shares of company stock valued at $7,797,595. Insiders own 1.30% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

HCA Healthcare Price Performance

HCA stock opened at $528.69 on Monday. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $552.90. The stock has a market capitalization of $118.23 billion, a PE ratio of 18.63, a price-to-earnings-growth ratio of 1.63 and a beta of 1.34. The company’s 50-day moving average is $493.99 and its 200-day moving average is $460.92.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the prior year, the company earned $6.22 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s payout ratio is 10.15%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Oppenheimer raised their price objective on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research report on Monday, December 15th. Leerink Partners lifted their target price on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Royal Bank Of Canada increased their price target on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Finally, Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.